Skip to main content

Table 1 Summary table of model parameters included

From: Cost-utility analysis of a consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients

Demographic characteristics of target group

Mean age

87.09 (SD 6.675)

Sex

75% women

Geographic characteristics of target group

Country

Spain

Region

Catalonia

Target population minimum age

65

Target population maximum age

90

 

Before Intervention

After intervention

Incidence rate of dementia in institutionalized patients in our area

40%

40%

Recovery rate

0%a

0%a

Relative Risk of Mortality in baseline health

1

1

Relative Risk of Mortality in dementia patientsb

1.51

1.31

Intervention one-off costs (per patient)

 

0

Intervention recurrent costs (per patient and year)

 

48.56€

Healthcare costs baseline health

0

0

Healthcare costs dementia patients

2266 €

1630 €

Utility

0.70

0.27

  1. aRecovery rate was considered 0% because once a patient is diagnosed with dementia there is no recovery. bEstimates on mortality rates were derived from the findings of the DART-AD [2] clinical trial. Baseline health costs were left at 0 since the intervention only focuses on patients that are already in a deteriorated health state (they already have dementia). The healthcare cost deteriorated health after intervention were calculated as the drug-related costs mean per patient recorded at 1 and 6 months after the intervention